Clinical Characteristics and Treatment Outcomes After First Achromobacter Isolation in Children with Cystic Fibrosis (Pre–CFTR Modulator Era)
- 1Division of Pediatric Pulmonology, Marmara University Faculty of Medicine, İstanbul, Türkiye
- 2Selim Coremen Cystic Fibrosis Center, Marmara University Faculty of Medicine, İstanbul, Türkiye
- 3Department of Medical Microbiology, Marmara University Faculty of Medicine, İstanbul, Türkiye
Abstract
OBJECTIVE: We aimed to describe the clinical and demographic characteristics of children with cystic fibrosis (cwCF) diagnosed with a first Achromobacter (Ach) isolation, and to evaluate treatment outcomes at our CF center during the pre-modulator era.
MATERIAL AND METHODS: We retrospectively reviewed children followed at a single CF center (2014–2021) with at least four respiratory cultures per year and ≥12 months of follow-up after first Ach isolation. Eradication was defined as no Ach isolation for 12 months after the first detection; persistent infection was defined as intermittent or chronic isolation according to the Leeds criteria. We compared clinical characteristics and 12-month outcomes between the eradicated and non-eradicated groups.
RESULTS: Forty children were included; mean age at first isolation was 10.9±7.0 years, and eradication was achieved in 19/40 (47.5%). The non-eradicated group was older at first isolation (12.7±8.0 vs. 8.5±5.1 years; P =0.04), had more pulmonary exacerbations (Pex) in the preceding year (median 4 vs. 2; P = 0.01), and more frequent prophylactic azithromycin use (67% vs. 21%; P = 0.01). Airway colonization patterns changed significantly over 12 months in the non-eradicated group (P < 0.001), with increased colonization by Pseudomonas aeruginosa (PA); changes were not significant in the eradicated group. Among those with available spirometry, 12-month forced expiratory volume in one second (FEV1) z-scores did not differ by eradication status after adjustment for the baseline FEV1 z-score.
CONCLUSION: Inthis pre–cystic fibrosis transmembrane conductance regulator modulator study, persistence of Ach was associated with older age, higher Pex burden before first isolation, and clinically relevant shifts in airway microbiology, including increased PA colonization. Our findings suggest that cwCF with frequent exacerbations or a worsening clinical course may warrant closer attention to Ach, and eradication of Ach may be considered at first detection.
Related
- Clinical characteristics and treatment analysis of children with glucose transporter type 1 deficiency syndrome: a report of two cases
- Clinical characteristics and treatment outcomes of neuroblastoma with pulmonary metastases.
- Treatment Adherence and its Association with Demographic Characteristics and Clinical Factors Among Patients with Hypertension: A Cross-Sectional, Descriptive-Correlational Study.
- Early-onset colorectal cancer in Korea: clinical characteristics, treatment patterns, and survival outcomes in a K-CURE nationwide population-based study
- Clinical characteristics and treatment strategies of ovarian teratomas associated with anti-N-methyl-D-aspartate receptor encephalitis based on a case series
BibTeX
@article{karabulut2026clinical,
title = {{Clinical Characteristics and Treatment Outcomes After First Achromobacter Isolation in Children with Cystic Fibrosis (Pre–CFTR Modulator Era)}},
author = {Şeyda Karabulut and Merve Selçuk Balcı and Mine Yüksel Kalyoncu and Aynur Gulieva and Mürüvvet Yanaz and Cansu Yılmaz Yeğit and Almala Pınar Ergenekon and Burcu Uzunoğlu and Gamze Taştan and Özgenur Demirkol and Ela Erdem Eralp and Yasemin Gökdemir and Ayşegül Karahasan and Fazilet Karakoç and Bülent Karadağ},
journal = {Thoracic Research and Practice},
year = {2026},
month = nov,
doi = {10.4274/thoracrespract.2026.2026-1-8},
url = {https://doi.org/10.4274/thoracrespract.2026.2026-1-8},
note = {CC BY-NC 4.0},
}
RIS
TY - JOUR
TI - Clinical Characteristics and Treatment Outcomes After First Achromobacter Isolation in Children with Cystic Fibrosis (Pre–CFTR Modulator Era)
AU - Şeyda Karabulut
AU - Merve Selçuk Balcı
AU - Mine Yüksel Kalyoncu
AU - Aynur Gulieva
AU - Mürüvvet Yanaz
AU - Cansu Yılmaz Yeğit
AU - Almala Pınar Ergenekon
AU - Burcu Uzunoğlu
AU - Gamze Taştan
AU - Özgenur Demirkol
AU - Ela Erdem Eralp
AU - Yasemin Gökdemir
AU - Ayşegül Karahasan
AU - Fazilet Karakoç
AU - Bülent Karadağ
PY - 2026
DA - 2026/11/03
JO - Thoracic Research and Practice
DO - 10.4274/thoracrespract.2026.2026-1-8
UR - https://doi.org/10.4274/thoracrespract.2026.2026-1-8
AB - OBJECTIVE: We aimed to describe the clinical and demographic characteristics of children with cystic fibrosis (cwCF) diagnosed with a first Achromobacter (Ach) isolation, and to evaluate treatment outcomes at our CF center during the pre-modulator era. MATERIAL AND METHODS: We retrospectively reviewed children followed at a single CF center (2014–2021) with at least four respiratory cultures per year and ≥12 months of follow-up after first Ach isolation. Eradication was defined as no Ach isolation for 12 months after the first detection; persistent infection was defined as intermittent or chronic isolation according to the Leeds criteria. We compared clinical characteristics and 12-month outcomes between the eradicated and non-eradicated groups. RESULTS: Forty children were included; mean age at first isolation was 10.9±7.0 years, and eradication was achieved in 19/40 (47.5%). The non-eradicated group was older at first isolation (12.7±8.0 vs. 8.5±5.1 years; P =0.04), had more pulmonary exacerbations (Pex) in the preceding year (median 4 vs. 2; P = 0.01), and more frequent prophylactic azithromycin use (67% vs. 21%; P = 0.01). Airway colonization patterns changed significantly over 12 months in the non-eradicated group (P < 0.001), with increased colonization by Pseudomonas aeruginosa (PA); changes were not significant in the eradicated group. Among those with available spirometry, 12-month forced expiratory volume in one second (FEV1) z-scores did not differ by eradication status after adjustment for the baseline FEV1 z-score. CONCLUSION: Inthis pre–cystic fibrosis transmembrane conductance regulator modulator study, persistence of Ach was associated with older age, higher Pex burden before first isolation, and clinically relevant shifts in airway microbiology, including increased PA colonization. Our findings suggest that cwCF with frequent exacerbations or a worsening clinical course may warrant closer attention to Ach, and eradication of Ach may be considered at first detection.
SN - 2979-9139
ER -